Leukotriene A4 hydrolase (LTA4H) inhibitors, compositions containing them, and methods of use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and inflammatory conditions.
A Novel Method for Preparing Isocyanides from N-Substituted Formamides with Chlorophosphate Compounds
作者:Yoshikazu Kitano、Genki Kobayashi、Tateo Saito
DOI:10.1055/s-0030-1260211
日期:2011.10
Treatment of N-substituted formamides with chlorophosphate compounds such as PhOPOCl2, EtOPOCl2, Me2NPOCl2, and (PhO)2POCl and tertiary amines such as triethylamine, pyridine, and N,N-diisopropylethylamine produced the corresponding isocyanides in high yields. This method can be used to prepare various alkyl and aryl isocyanides. isocyanide - isonitrile - formamide - dehydration - dichlorophosphate
[EN] PHENYL AND PYRIDYL LTA4H MODULATORS<br/>[FR] MODULATEURS LTA4H DE PHENYLE ET PYRIDYLE
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2006105304A2
公开(公告)日:2006-10-05
(EN) Leukotrfene A4 hydrolase (LTA4H) inhibitors, compositions containing them, and methods of use for the inhibition of LTA4H enzyme activity and the treatment, prevention or inhibition of inflammation and inflammatory conditions.(FR) L'invention concerne des inhibiteurs de leucotriène A4 hydrolase (LTA4H), des compositions renfermant lesdits inhibiteurs ainsi que leurs procédés d'utilisation à des fins d'inhibition de l'activité de l'enzyme LTA4H et pour traiter, prévenir ou inhiber les inflammations ou les états inflammatoires.
Rational design and synthesis of 1,5-disubstituted tetrazoles as potent inhibitors of the MDM2-p53 interaction
作者:Ewa Surmiak、Constantinos G. Neochoritis、Bogdan Musielak、Aleksandra Twarda-Clapa、Katarzyna Kurpiewska、Grzegorz Dubin、Carlos Camacho、Tad A. Holak、Alexander Dömling
DOI:10.1016/j.ejmech.2016.11.029
日期:2017.1
Using the computational pharmacophore-based ANCHOR.QUERY platform a new scaffold was discovered. Potent compounds evolved inhibiting the protein-protein interaction p53-MDM2. An extensive SAR study was performed based on our four-point pharmacophore model, yielding derivatives with affinity to MDM2 in the nanomolar range. Their binding affinity with MDM2 was evaluated using both fluorescence polarization